AbbVie reaches deal with Trump administration on drug prices
AbbVie reached a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future price mandates. AbbVie reaches deal with Trump administration on drug prices in exchange for tariff relief North Chicago-based AbbVie has become the latest drugmaker to reach a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future price mandates, the company announced Monday evening. Read Story Related articles: AbbVie to invest $195 million in North Chicago facility that will produce active pharmaceutical ingredients © Copyright 2026 Chicago Tribune. All rights reserved. 1000 Albion Avenue | Schaumburg, IL 60193-4549 Unsubscribe